Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Quebec, QC, Canada.
The University of British Columbia Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.
Commun Biol. 2021 Jun 8;4(1):700. doi: 10.1038/s42003-021-02227-6.
To identify candidate causal genes of asthma, we performed a genome-wide association study (GWAS) in UK Biobank on a broad asthma definition (n = 56,167 asthma cases and 352,255 controls). We then carried out functional mapping through transcriptome-wide association studies (TWAS) and Mendelian randomization in lung (n = 1,038) and blood (n = 31,684) tissues. The GWAS reveals 72 asthma-associated loci from 116 independent significant variants (P < 5.0E-8). The most significant lung TWAS gene on 17q12-q21 is GSDMB (P = 1.42E-54). Other TWAS genes include TSLP on 5q22, RERE on 1p36, CLEC16A on 16p13, and IL4R on 16p12, which all replicated in GTEx lung (n = 515). We demonstrate that the largest fold enrichment of regulatory and functional annotations among asthma-associated variants is in the blood. We map 485 blood eQTL-regulated genes associated with asthma and 50 of them are causal by Mendelian randomization. Prioritization of druggable genes reveals known (IL4R, TSLP, IL6, TNFSF4) and potentially new therapeutic targets for asthma.
为了鉴定哮喘的候选致病基因,我们在英国生物银行(UK Biobank)开展了一项全基因组关联研究(GWAS),其针对广泛的哮喘定义(n=56167 例哮喘病例和 352255 例对照)。然后,我们通过转录组全基因组关联研究(TWAS)和肺(n=1038)及血液(n=31684)组织的孟德尔随机化进行功能映射。GWAS 揭示了来自 116 个独立显著变异体(P<5.0E-8)的 72 个哮喘相关位点。在 17q12-q21 上的肺 TWAS 基因中,最显著的是 GSDMB(P=1.42E-54)。其他 TWAS 基因包括 5q22 上的 TSLP、1p36 上的 RERE、16p13 上的 CLEC16A 和 16p12 上的 IL4R,这些基因在 GTEx 肺组织(n=515)中均得到了复制。我们证明,在与哮喘相关的变异体中,调节和功能注释的最大富集倍数在血液中。我们鉴定出与哮喘相关的 485 个血液 eQTL 调控基因,其中 50 个通过孟德尔随机化被确定为因果基因。对可成药基因的优先级排序揭示了已知(IL4R、TSLP、IL6、TNFSF4)和潜在的新的哮喘治疗靶点。